Ying Huang

3PUBLICATIONS
37CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 14, 2022
Combined BCL2 and BTK inhibition in CLL demonstrates efficacy after monotherapy with both classes.

Jonathan M Hyak, Ying Huang, Kerry A Rogers

|May 24, 2022
Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study.

Deborah M Stephens, Ying Huang, Amy S Ruppert

Pageof 1